Abstract: Among endogenous adaptive systems to hypoxia, neuroglobin, a recently discovered heme protein, was suggested as a novel oxygen-dependent neuroprotectant. We aimed to characterize i) maturational age-related regulation of neuroglobin in the developing mouse brain under normoxic and hypoxic conditions, and ii) the role of hypoxia-inducible transcription factors (HIFs) as possible mediators of O(2)-dependent regulation of neuroglobin in vitro and in vivo. During early stages of postnatal brain maturation (P0-P14) neuroglobin mRNA levels significantly increased in developing mouse forebrains. By immunohistochemical analysis we confirmed expression of neuroglobin protein in the cytoplasm of developing neurons but not glial cells under normoxic conditions. Exposure of the immature brains (P0, P7) to acute (8% O(2), 6h) and chronic systemic hypoxia (10% O(2), 7days) led to differential activation of neuroglobin varying with maturational stage (P0, P7) and severity of hypoxia. This observation may indicate that neuroglobin is involved in adaptive responses of immature neurons to acute hypoxia during an early stage of mouse brain maturation (P0). In response to activation of the HIF system by prolyl-4-hydroxylase inhibitor (FG-4497), neuroglobin mRNA expression was significantly up-regulated in primary mouse cortical neurons (DIV6) exposed to normoxia and hypoxia (1% O(2)) compared to nontreated controls. In conclusion, present results strongly indicate that cerebral regulation of neuroglobin is related to maturational stage and that hypoxia-induced neuroglobin up-regulation is modified by the HIF system. 
Abstract
Among endogenous adaptive systems to hypoxia, neuroglobin has been suggested as a novel oxygen-dependent neuroprotectant. However, neuroglobin´s protective role in postnatal susceptibility to hypoxic brain injury, as well as the mechanism underlying hypoxic regulation of neuroglobin, remains to be elucidated.
We aimed to characterize i) maturational age-related regulation of neuroglobin in developing mouse brain in normoxic and hypoxic conditions, and ii) the role of hypoxia-inducible transcription factors (HIFs) as possible mediators of O 2 -dependent regulation of neuroglobin.
In normoxia we showed that neuroglobin expression is regulated postnatally with increasing neuroglobin mRNA levels observed during brain maturation (P0-P14). By immunohistochemical analysis, we observed that neuroglobin is localized mainly in the cytoplasm of neurons. Exposure to acute (8% O 2 , 6h) and chronic systemic hypoxia (10% O 2 , 7d) revealed that the neuroglobin response to hypoxia varies with maturational stage (P0 vs. P7) as well as with the severity of hypoxia, indicating a role for neuroglobin in neuronal acclimatisation to acute hypoxia during early stages of mouse brain maturation (P0). We also investigated neuroglobin regulation in primary mouse cortical neurons (DIV6) exposed to hypoxia (1% O 2 ) in the presence or absence of the novel HIF prolyl hydroxylase inhibitor, FG-4497. The data generated strongly supports the notion that hypoxia-induced neuroglobin up-regulation is HIF-dependent.
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Introduction
Hypoxic and ischemic complications during the pre-and perinatal period are common causes of acquired neonatal brain damage (Rutherford et al., 2006) . Clinical situations representing risk factors for perinatal brain injury include maternal hypotension or anemia, placental or umbilical cord complications (Low, 2004) , as well as chronically compromised prenatal fetal oxygen supply due to placental abnormalities or maternal diseases (Terzidou and Bennett, 2001 ). The complex neurotoxic cascade following cerebral hypoxic injury develops over a specific period of time when immediate early genes, inflammatory and excitotoxic pathways and, finally, apoptotic neurodegeneration are activated in vulnerable CNS regions such as cerebral cortex, hippocampus (CA1, CA3) and striatum (Northington et al., 2001 ).
Among endogenous cerebral adaptive systems to hypoxia and ischemia, neuroglobin (Ngb), a recently discovered heme protein expressed in neurons of the central and peripheral nervous system and retina was suggested as a new neuroprotectant which is regulated by oxygen levels. In vitro, hypoxia has been shown to up-regulate Ngb transcript and protein expression in mouse cortical neurons (Sun et al., 2001) , human glioblastoma (Emara et al., 2009 ) and neuronal cell lines (Schmidt-Kastner et al., 2006 , Shao et al., 2009 ). Moreover, increased Ngb expression in hypoxic adult rat brains (Li et al., 2006 , Shao et al., 2009 as well as in focal cerebral ischemia (Sun et al., 2001 ) has been demonstrated. However, the in vivo observations are contradictory (Hundahl et al., 2005 , Li et al., 2006 , Schmidt-Kastner et al., 2006 ) with findings varying depending on the experimental model used. Notably, studies on Ngb expression and regulation in developing brain, as well as its role in early response to cerebral hypoxia, are not available.
Mechanisms underlying hypoxic induction of Ngb are still unclear. From in vitro experiments, involvement of hypoxia-inducible transcription factors (HIFs) (Sun et al., 2001) and hemin via the soluble guanylate cyclase/protein kinase G pathway (Zhu et al., 2002) have been proposed. Expression of Ngb was shown to be significantly induced in mouse cortical neurons by CoCl 2 and deferoxamine (DFO) (Sun et al., 2001 ). This compounds can stabilize the O 2 -regulated α-subunits of HIF which then heterodimerize with the constitutively expressed β-subunit to form an active HIF complex (Fandrey et al., 2006) . Under normoxic conditions, HIF-α subunits are degraded rapidly by the ubiquitin-proteasome pathway, a process that is mediated via hydroxylation of specific prolyl residues by an enzyme family of HIF prolyl hydroxylases (prolyl hydroxylation domain protein [PHD] ) that utilize di-oxygen and 2-oxoglutarate as co-substrates. Reduced activity of the PHDs, e.g. at low oxygen levels or by iron chelation, results in stabilisation of the HIF-α protein, heterodimerization (α/β), and nuclear translocation followed by binding to hypoxia response elements in promoters of specific responsive genes. HIFs up-regulate transcription of a cascade of hypoxia-inducible genes including erythropoietin, pro-apoptotic mediators (e.g. BNIP3), and vasoactive factors such as vascular endothelial growth factor (VEGF) and adrenomedullin (ADM), all of which can modify immediate cerebral response to hypoxia and ischemia in the adult (Stroka et al., 2001 ) as well as developing brain (Bernaudin et al., 2002 , Trollmann et al., 2008b . Based on these observations, involvement of HIF-1 in the hypoxic induction of cerebral Ngb expression has been hypothesized (Sun et al., 2001 ).
To analyze HIF stabilization using a pharmacological agent that is more specific than CoCl 2 and DFO, we have used a novel prolyl-4-hydroxylase inhibitor, FG-4497 (Schneider et al., 2009 ). FG-4497 inhibits the HIF-PHDs, stabilizes HIF-α subunits, and thus enhances formation of a functional HIF complex.
Functionally, Ngb has been shown to protect neurons from hypoxic injury in vitro (Liu et al., 2009 ) and in vivo in adult wild-type mice (Shao et al., 2009 ) and in Ngb-overexpressing transgenic mice (Sun et al., 2003) . The protective properties of Ngb may be due to its ability to act as scavenger of reactive oxygen and nitrogen species (Brunori et al., 2005 , Fordel et al., 2007 and to maintain mitochondrial function (Liu et al., 2009 ). Furthermore, anti-apoptotic effects of Ngb via reduction of cytochrom c have been reported (Fago et al., 2006 , Raychaudhuri et al., 2009 . The role of Ngb in age-related susceptibility to hypoxic/ischemic brain injury remains to be established.
The aim of the present study was to characterize maturational postnatal expression of Ngb in developing mouse brain during normoxia and systemic hypoxia using a mouse model of acute and chronic perinatal hypoxia (Trollmann et al., 2008a) . In addition, in vitro and in vivo experiments were performed to understand the role of HIF in hypoxia-induced induction of Ngb.
Methods
Animal experiments. Neonatal C57BL/6 wild-type mice (Charles River Laboratories, Germany) were exposed to acute and chronic systemic hypoxia using a closed hypoxia Animal experiments were performed according to protocols approved by local government (Regierung Mittelfranken, Germany) according to national and European law.
After the incubation period, neonatal brains were immediately dissected (without reoxygenation of the hypoxic groups), frozen in liquid nitrogen and stored at -80 °C until protein (n=3 per group) and mRNA extraction (n=5 per group) was performed. For immunohistochemical studies, brains (n=3 per group) were embedded in 4% paraformaldehyde. Coronal sections at the level of the dorsal hippocampus were examined to analyze parietal cortex and hippocampus known to show selective vulnerability to hypoxia at early development. Mouse brain maturation at P0 and P7 approximately corresponds to that of the human brain at mid-gestation and near-term, respectively (Dobbing and Sands, 1979) .
Pharmacological HIF stabilization. Neonatal C57BL/6 wild-type mice were treated with the HIF prolyl hydroxylase inhibitor (PHI) FG-4497 (FibroGen; San Francisco; USA) under normoxic conditions at P0 (n=15) or P7 (n=15). FG-4497 (patent-registered US20040254215A1) was dissolved according to the instructions of the manufacturer (100 mg FG-4497 to 9.675 ml of 5% Dextrose to 325 µl of 1 N NaOH), and was injected i.p. (injection volume 0.1 ml) in a single dose of 30 (n=5), 60 (n=5) and 100 mg/kg (n=5). Age-matched controls were treated with NaCl 0.9% i.p. (n=10) or remained non-treated (n=10). After the treatment period of 6 h, PHI-treated brains and controls were dissected, frozen in liquid nitrogen and stored at -80°C until mRNA extraction. A 6-hour treatment interval was decided according to observations on protective effects of other PHI than FG-4497 in vivo in adult rats (Siddiq et al., 2005 , Bernhardt et al., 2006 . Specificity of FG-4497 has been shown in adult and neonatal mouse brain (Schneider et al., 2009) .
Primary cortical neuronal cultures. The dorsal telencephalon was dissected from E14
C57BL/6 wild-type mice (Charles River Laboratories, Germany) following a published protocol (Sestan et al., 1999) . Briefly, cortices of E14 mouse pups were dissected aseptically in cold 1x HBSS (+) solution with MgCl 2 and CaCl 2 following decapitation. The meninges were removed, cortices were collected in 1x HBSS (+) and after washing in 1x HBSS (-) without MgCl 2 and CaCl 2 but with Pyruvate were treated with trypsin DNAse. After washing in DMEM solution with Pyruvate and fetal calf serum, tissues were dissociated by triturating in serum free media to make a single cell suspension. The serum free medium conditions. Cell viability was assessed by lactate dehydrogenase measurement. Experiments were performed at least three times. Cells were lysed and probed for HIF-1α by western blot analysis as previously described (Trollmann et al., 2008b) . Blots were quantified desitometrically using the MCID imaging system (Imaging Research). β-actin was used as a loading control.
RNA isolation and RT-PCR.
Total RNA was extracted from whole mouse brains and primary cortical neurons using Trizol isolation method (Invitrogen, Germany). RT-PCR was performed as described previously (Trollmann et al. 2008a, b) . One µg of total RNA was used for each reverse transcription (MMLV reverse transcriptase, Invitrogen, Germany). RT cDNA products were measured by quantitative TaqMan RT-PCR. Commercial reagents (TaqMan PCR Reagent Kit, Perkin-Elmer Corp.) and conditions were applied according to the manufacturer´s protocol. The PCR reaction was performed in an ABI 7500 real-time PCR thermocycler (Applied Biosystems). All reactions were performed in duplicate using ß-actin and porphobilinogen deaminase (PBGD) as endogenous controls.
The following primers and TaqMan probes based on published reports were used: 
Results
Cerebral Ngb expression is related to maturational stage. To evaluate maturational agerelated expression levels of Ngb during postnatal mouse brain development, we measured cerebral Ngb mRNA levels in normoxic brains of mice from 0 to 21 days of postnatal age and at P60. As demonstrated in Fig. 1 , Ngb mRNA levels increased during the first postnatal weeks from P0 to P14 reaching peak levels at P14, and declined thereafter reaching levels comparable to those of adult brains (P60) at the end of third postnatal week.
Immunohistochemical analysis revealed neuronal but not glial expression of Ngb throughout the developing cerebral cortex at P7 (Fig. 2) . Of note, Ngb-positive neurons were found most prominently in cortical layers II/III.
Cerebral Ngb expression is related to the degree of hypoxia. To investigate effects of hypoxia on cerebral Ngb expression during early postnatal brain development, we analyzed Ngb mRNA and protein expression in brains of neonatal mice at the age of P0 and P7 exposed to acute or chronic hypoxia. Whereas acute systemic hypoxia (8% O 2 ) for 6 hours did not markedly alter cerebral Ngb mRNA levels at P7, there was a significant up-regulation of Ngb mRNA concentrations at P0 compared to controls (Fig. 3A) . However, hypoxia-induced Ngb up-regulation did not persist during reoxygenation (21% O 2 for 24 h, 72 h, and 7 d) following exposure to acute hypoxia (Fig. 3B) . The increase of cerebral Ngb mRNA concentrations with postnatal age in normoxic brains (Fig. 3B ) reflects an age-related phenomenon as shown in Fig. 1 . Interestingly, this age-specific up-regulation of Ngb appeared to be transiently suppressed upon acute hypoxia (Fig. 3B) as suggested by unchanged mean Ngb mRNA levels during the first 72 h of reoxygenation in contrast to normoxic controls.
To confirm the severity of acute hypoxia used in our experimental setting, several hypoxiainducible genes as well as markers of apoptosis were analyzed (Fig. 4 A-G) . At both maturational stages P0 and P7, mRNA expression of HIF-regulated vasoactive and neurotrophic factors (ADM, EPO) and pro-apoptotic genes (BNIP3, IER3) was significantly increased compared to normoxic controls with no apparent age-related differences. Similarly, cerebral mRNA concentrations of the HIF-dependent PHD2 and PHD3 isoforms (Fig 4E, F) were up-regulated during acute hypoxia compared to normoxic controls in both P0 and P7
brains. In contrast, mRNA levels of the proapoptotic HIF target gene DUSP1 were significantly elevated in hypoxic developing brain at P0 compared to controls but not at P7 (Fig. 4G) Since acute hypoxia was found to be a stimulus for Ngb induction during early brain development, cellular and spatial distribution of Ngb in hypoxic developing brains was determined by immunohistochemistry (Fig. 6) . A hypoxia-induced increase in Ngb at P0 was confirmed at the protein level by demonstrating a markedly higher number of Ngb-positive cells in the parietal cortex of hypoxic compared to normoxic mouse brains (Fig. 6 A vs B) .
This was in contrast to hypoxic mouse brains at P7, in which there was an unchanged number and distribution pattern of Ngb-positive cells compared to controls (Fig. 6 C vs D) . Notably, co-staining with NeuN and GFAP demonstrated cytoplasmic accumulation of Ngb in hypoxic neurons (Fig. 2C, D) but not glia cells (Fig. 2B ) throughout the developing cerebral cortex.
To determine whether Ngb expression is also modulated by chronic hypoxia during early stages of brain maturation, analyses were extended to brains exposed to systemic chronic hypoxia at P7 (10% O 2 for 7 d). As demonstrated in Table 1 , cerebral Ngb mRNA levels did not significantly differ between chronic hypoxic and normoxic tissues either at the end of hypoxic exposure or during reoxygenation periods. To compare Ngb mRNA levels to other HIF-regulated genes, we determined mRNA concentrations of BNIP3, ADM, EPO, PHD2
and PHD3, DUSP1 and IER3. In contrast to our observations during acute hypoxia, there were no significant differences in selected HIF target gene expression between normoxic and hypoxic brain except for a significant EPO up-regulation, and, of note, a more than 2-fold increase of BNIP3 mRNA levels following a 24 hr reoxygenation period in comparison to normoxic controls (Table 1) .
Hypoxic induction of cerebral Ngb expression is mediated by HIF.
To examine whether hypoxia-induced up-regulation of Ngb expression is mediated by HIF stabilization and activation during acute hypoxia, two approaches were taken. First, by in vitro experiments with mouse embryonic neuronal cultures (E14, DIV6) we compared induction of Ngb mRNA levels between neurons exposed to hypoxia (1% O 2 , 6h) and in neurons pre-treated with FG-4497 (0.1-1 µM) before incubation under either normoxic or hypoxic conditions. Hypoxia induced a more than three-fold increase in Ngb mRNA levels compared to controls (Fig. 7A ).
Similar transcriptional activation of Ngb was found in response to FG-4497 under normoxia ( conditions compared with hypoxic controls (Fig. 7B) . Conversely, additive effects of hypoxia and FG-4497 are observed for the HIF-dependent gene, ADM (Fig. 7D ). BNIP3 mRNA levels on the other hand, increased in response to hypoxia and FG-4497 without comparable additive effects (Fig. 7C ).
The second approach taken was to analyze cerebral Ngb expression in vivo in response to PHI treatment (30, 60 and 100 mg/kg, i.p.) under normoxic conditions (Table 2 ). No significant difference in mean Ngb mRNA expression level was detected between vehicle-treated and FG-4497-treated neonatal mouse brains at both maturational stages P0 and P7. In addition,
Discussion
A wide spectrum of endogenous hypoxia-inducible mediators are involved in critical mechanisms of early brain maturation (Fandrey et al., 2006) as well as compensation during hypoxic and ischemic injury of the developing brain (Curristin et al., 2002 Thus, present data extend previous findings on age-specific regulation of Ngb expression which demonstrated an age-related decline in 3 to 12-month-old rodents (Sun et al., 2005) .
Previous studies on adult mouse brain have suggested multi-regional expression of Ngb (Wystub et al., 2003) , whereas others have not been able to detect either Ngb-positive neurons (Mammen et al., 2002) or glia cells (Hundahl et al., 2005) but not at P7. In contrast, studies on adult mice showed no detectable difference in cerebral
Ngb expression between normoxic and hypoxic brains either at the protein or mRNA levels upon short-term hypoxia (7.6% O 2, 2h) (Hundahl et al., 2005) . In accordance with PCR and ISH studies on adult mouse brain under chronic hypoxic conditions (10% O 2 ; up to two weeks) (Mammen et al., 2002) we did not detect any differences in Ngb expression between chronically hypoxic brains and normoxic controls either at P0 or at P7, even with reoxygenation periods up to 7d (data not shown). Thus, present results suggest that Ngb transcriptional regulation is affected by acute but not by chronic hypoxia, and interestingly, that acute hypoxic induction of cerebral Ngb represents an age-dependent, transient phenomenon during early brain development. Although there are conflicting hypotheses about the potential effects of PHI treatment in neonatal brain (Chen et al., 2009) , pharmacologic inhibition of PHD hydroxylation leading to HIF accumulation has been proposed as a possible target for neuroprotection (Siddiq et al., 2005 , Adamcio et al., 2009 ). In vitro, HIF stabilization by FG-4497 has been shown to enhance proliferation, neurogenesis and differentiation of human neural progenitor cells (Milosevic et al., 2009) . In contrast, depending on the degree of hypoxia and the cell type induction of pro-apoptotic mechanisms has been linked to overexpression of HIF (Helton et al., 2005 , Chen et al., 2009 . This is of special significance in the developing brain as since disturbance of physiological apoptosis which plays a crucial role in early brain development (Sandau and Handa, 2006) , might be detrimental. In accordance to reported evidence that HIF-1 induces BNIP3 expression (Guo et al., 2001) , we have shown a significant upregulation of cerebral BNIP3 mRNA levels in response to FG-4497 in vitro under normoxic conditions. Notably, this was not confirmed in vivo. BNIP3 is known as a central mediator of hypoxia-induced autophagy that could result in adaptive survival as well as cell death depending on the degree of hypoxia (Tracy et al., 2007 , Bellot et al., 2009 . In contrast to severe hypoxic conditions or anoxia (<0.1% O 2 ) which trigger HIF-independent autophagic response, sublethal hypoxia (as used in our model) induces mitochondria-associated proteins BNIP3 and BNIP3L (NIX) which have been suggested to mediate a metabolic adaptation for survival by their ability to control reactive oxygen species production and DNA damage (Bellot et al., 2009) . Of interest, Aminova et al. (2008) showed that antioxidants and PHD inhibitors prevent HIF-mediated transactivation of BH3-only proteins minimizing pro-death effects of HIF-1α overexpression on neurons exposed to oxidative stress. We intend to address functional significance of early Ngb versus BNIP3 induction by pharmacological HIF overexpression in the hypoxic developing mouse brain in future studies.
Hypoxic induction of cerebral
In conclusion, our in vivo results demonstrate for the first time that Ngb expression increases age-dependently in the developing mouse brain and that Ngb expression in response to hypoxia varies with maturational stage as well as the degree of hypoxia, indicating a role in neuronal adaptation to acute hypoxia during early stage of mouse brain maturation (P0).
Regarding hypoxic regulation of Ngb, our in vitro results suggest involvement of HIFdependent mechanisms. Taken together, our data provide basic information for further investigations on pathophysiology of postnatal cerebral hypoxic response in view of novel and maturational-age specific neuroprotective concepts. Fig. 1 Ngb mRNA expression normalized to β-actin in mouse brain in relation to maturational age P0-P60 . N=4 per group, **p<0.01 
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